The FDA cleared the Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo. ICU Medical also got the FDA’s green light for updated versions of its Plum Duo pump and LifeShield infusion safety software. This completes the initial launch of the company’s IV Performance Platform.
With the clearances, ICU Medical said it’s introducing a new category of precision IV pumps and expanding its IV Performance Platform.
ICU Medical built its precision pumps to address delivery variability while supporting the increasing need for accurate data. Plum Solo and Plum Duo, based on the unique cassette technology in the company’s Plum 360 pump, deliver more accuracy in real-world conditions and eliminate the infusion consistencies found in traditional pumps. The company says they provide clinicians with predictable performance and reliable infusion documentation.
Plum Solo expands the capabilities of the IV Performance Platform as a single-channel pump to work alongside the dual-channel Plum Duo. This provides the flexibility of choosing the right configuration for certain infusion needs. The pumps allow for accurate and precise medication delivery, including whole blood and blood products.
With a simplified user experience, the pumps also offer streamlined medication management and full IV-EHR interoperability.
“Precision IV pumps represent a critical step forward for infusion therapy,” said Chad Jansen, corporate vice president and general manager of ICU Medical Infusion Systems. “With the Plum Solo and Plum Duo, we’re introducing more than just a new device category—we’re setting a new standard. Healthcare teams can now trust not only the delivery of their medications but also the infusion data that supports their decisions, knowing it reflects what patients actually receive.”
“We are proud of this milestone, but this is just the next step in creating the most comprehensive, precise, and technologically advanced infusion platform,” Jansen said. “This milestone delivers on our promised roadmap with 5 products receiving FDA 510(k) clearance in the past 18 months. We look forward to bringing our next-generation MedfusionTM syringe pump and CADDTM pain and ambulatory pump products to the LifeShield platform. This is the future of infusion therapy, and we’re proud to be leading the way.”
